Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Non Operating Income: 2021-2025

Historic Non Operating Income for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $3.4 million.

  • Prime Medicine's Non Operating Income rose 97.84% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 5.88%. This contributed to the annual value of $6.6 million for FY2024, which is 3.21% up from last year.
  • Per Prime Medicine's latest filing, its Non Operating Income stood at $3.4 million for Q3 2025, which was up 331.42% from $786,000 recorded in Q2 2025.
  • Prime Medicine's 5-year Non Operating Income high stood at $3.4 million for Q3 2025, and its period low was -$8.4 million during Q3 2021.
  • For the 3-year period, Prime Medicine's Non Operating Income averaged around $1.8 million, with its median value being $1.9 million (2024).
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 406.51% in 2023, then plummeted by 92.73% in 2024.
  • Prime Medicine's Non Operating Income (Quarterly) stood at -$1.5 million in 2021, then soared by 46.15% to -$783,000 in 2022, then soared by 406.51% to $2.4 million in 2023, then declined by 18.92% to $1.9 million in 2024, then surged by 97.84% to $3.4 million in 2025.
  • Its Non Operating Income was $3.4 million in Q3 2025, compared to $786,000 in Q2 2025 and $502,000 in Q1 2025.